We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Thermo Fisher (TMO) Reliance on International Sales: What Investors Need to Know
Read MoreHide Full Article
Have you evaluated the performance of Thermo Fisher Scientific's (TMO - Free Report) international operations for the quarter ending September 2025? Given the extensive global presence of this maker of scientific instrument and laboratory supplies, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.
In the current era of a tightly interconnected global economy, the proficiency of a company to penetrate international markets significantly influences its financial health and trajectory of growth. For investors, the key is to grasp how reliant a company is on overseas markets, as this provides insights into the durability of its earnings, its ability to exploit different economic cycles, and its overall growth capabilities.
Being present in international markets serves as a counterbalance to domestic economic challenges while offering chances to engage with more rapidly evolving economies. However, this kind of diversification introduces challenges like currency fluctuations, geopolitical uncertainties and varying market trends.
Our review of TMO's last quarterly performance uncovered some notable trends in the revenue contributions from its international markets, which are commonly analyzed and tracked by Wall Street experts.
The company's total revenue for the quarter amounted to $11.12 billion, showing rise of 4.9%. We will now explore the breakdown of TMO's overseas revenue to assess the impact of its international operations.
Decoding TMO's International Revenue Trends
Other regions generated $415 million in revenues for the company in the last quarter, constituting 3.7% of the total. This represented a surprise of +9.5% compared to the $379.01 million projected by Wall Street analysts. Comparatively, in the previous quarter, Other regions accounted for $383 million (3.5%), and in the year-ago quarter, it contributed $397 million (3.8%) to the total revenue.
Of the total revenue, $2.01 billion came from Asia-Pacific during the last fiscal quarter, accounting for 18.1%. This represented a surprise of +1.01% as analysts had expected the region to contribute $1.99 billion to the total revenue. In comparison, the region contributed $1.92 billion, or 17.7%, and $1.92 billion, or 18.1%, to total revenue in the previous and year-ago quarters, respectively.
Europe accounted for 27% of the company's total revenue during the quarter, translating to $3.01 billion. Revenues from this region represented a surprise of +8.49%, with Wall Street analysts collectively expecting $2.77 billion. When compared to the preceding quarter and the same quarter in the previous year, Europe contributed $2.83 billion (26.1%) and $2.69 billion (25.3%) to the total revenue, respectively.
Anticipated Revenues in Overseas Markets
It is projected by analysts on Wall Street that Thermo Fisher will post revenues of $11.94 billion for the ongoing fiscal quarter, an increase of 4.8% from the year-ago quarter. The expected contributions from Other regions, Asia-Pacific and Europe to this revenue are 3.6%, 18%, and 25.8%, translating into $429.55 million, $2.15 billion, and $3.08 billion, respectively.
For the full year, the company is projected to achieve a total revenue of $44.23 billion, which signifies a rise of 3.2% from the last year. The share of this revenue from various regions is expected to be: Other regions at 3.5% ($1.55 billion), Asia-Pacific at 18% ($7.94 billion), and Europe at 25.7% ($11.37 billion).
Final Thoughts
The dependency of Thermo Fisher on global markets for its revenues presents a mix of potential gains and hazards. Thus, monitoring the trends in its overseas revenues can be a key indicator for predicting the firm's future performance.
In a world where international interdependencies and geopolitical conflicts are ever-increasing, Wall Street analysts closely monitor these trends for companies having international presence to adjust their earnings forecasts. Of course, there are several other factors, including a company's standing within its home borders, that influence analysts' earnings forecasts.
We at Zacks strongly focus on the dynamic earnings forecast of companies, given that empirical studies have demonstrated its potent impact on the immediate price movement of stocks. Invariably, there's a positive relationship -- upward earnings predictions often result in an increase in stock prices.
Our proprietary stock rating tool, the Zacks Rank, with its externally validated exceptional track record, harnesses the power of earnings estimate revisions to serve as a dependable measure for anticipating the short-term price trends of stocks.
A Review of Thermo Fisher Scientific's Recent Stock Market Performance
The stock has increased by 4.4% over the past month compared to the 2.4% increase of the Zacks S&P 500 composite. Meanwhile, the Zacks Medical sector, which includes Thermo Fisher,has increased 6.8% during this time frame. Over the past three months, the company's shares have experienced a gain of 23.2% relative to the S&P 500's 8.2% increase. Throughout this period, the sector overall has witnessed a 13.3% increase.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Thermo Fisher (TMO) Reliance on International Sales: What Investors Need to Know
Have you evaluated the performance of Thermo Fisher Scientific's (TMO - Free Report) international operations for the quarter ending September 2025? Given the extensive global presence of this maker of scientific instrument and laboratory supplies, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.
In the current era of a tightly interconnected global economy, the proficiency of a company to penetrate international markets significantly influences its financial health and trajectory of growth. For investors, the key is to grasp how reliant a company is on overseas markets, as this provides insights into the durability of its earnings, its ability to exploit different economic cycles, and its overall growth capabilities.
Being present in international markets serves as a counterbalance to domestic economic challenges while offering chances to engage with more rapidly evolving economies. However, this kind of diversification introduces challenges like currency fluctuations, geopolitical uncertainties and varying market trends.
Our review of TMO's last quarterly performance uncovered some notable trends in the revenue contributions from its international markets, which are commonly analyzed and tracked by Wall Street experts.
The company's total revenue for the quarter amounted to $11.12 billion, showing rise of 4.9%. We will now explore the breakdown of TMO's overseas revenue to assess the impact of its international operations.
Decoding TMO's International Revenue Trends
Other regions generated $415 million in revenues for the company in the last quarter, constituting 3.7% of the total. This represented a surprise of +9.5% compared to the $379.01 million projected by Wall Street analysts. Comparatively, in the previous quarter, Other regions accounted for $383 million (3.5%), and in the year-ago quarter, it contributed $397 million (3.8%) to the total revenue.
Of the total revenue, $2.01 billion came from Asia-Pacific during the last fiscal quarter, accounting for 18.1%. This represented a surprise of +1.01% as analysts had expected the region to contribute $1.99 billion to the total revenue. In comparison, the region contributed $1.92 billion, or 17.7%, and $1.92 billion, or 18.1%, to total revenue in the previous and year-ago quarters, respectively.
Europe accounted for 27% of the company's total revenue during the quarter, translating to $3.01 billion. Revenues from this region represented a surprise of +8.49%, with Wall Street analysts collectively expecting $2.77 billion. When compared to the preceding quarter and the same quarter in the previous year, Europe contributed $2.83 billion (26.1%) and $2.69 billion (25.3%) to the total revenue, respectively.
Anticipated Revenues in Overseas Markets
It is projected by analysts on Wall Street that Thermo Fisher will post revenues of $11.94 billion for the ongoing fiscal quarter, an increase of 4.8% from the year-ago quarter. The expected contributions from Other regions, Asia-Pacific and Europe to this revenue are 3.6%, 18%, and 25.8%, translating into $429.55 million, $2.15 billion, and $3.08 billion, respectively.For the full year, the company is projected to achieve a total revenue of $44.23 billion, which signifies a rise of 3.2% from the last year. The share of this revenue from various regions is expected to be: Other regions at 3.5% ($1.55 billion), Asia-Pacific at 18% ($7.94 billion), and Europe at 25.7% ($11.37 billion).
Final Thoughts
The dependency of Thermo Fisher on global markets for its revenues presents a mix of potential gains and hazards. Thus, monitoring the trends in its overseas revenues can be a key indicator for predicting the firm's future performance.
In a world where international interdependencies and geopolitical conflicts are ever-increasing, Wall Street analysts closely monitor these trends for companies having international presence to adjust their earnings forecasts. Of course, there are several other factors, including a company's standing within its home borders, that influence analysts' earnings forecasts.
We at Zacks strongly focus on the dynamic earnings forecast of companies, given that empirical studies have demonstrated its potent impact on the immediate price movement of stocks. Invariably, there's a positive relationship -- upward earnings predictions often result in an increase in stock prices.
Our proprietary stock rating tool, the Zacks Rank, with its externally validated exceptional track record, harnesses the power of earnings estimate revisions to serve as a dependable measure for anticipating the short-term price trends of stocks.
Currently, Thermo Fisher holds a Zacks Rank #3 (Hold), signifying its potential to match the overall market's performance in the forthcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
A Review of Thermo Fisher Scientific's Recent Stock Market Performance
The stock has increased by 4.4% over the past month compared to the 2.4% increase of the Zacks S&P 500 composite. Meanwhile, the Zacks Medical sector, which includes Thermo Fisher,has increased 6.8% during this time frame. Over the past three months, the company's shares have experienced a gain of 23.2% relative to the S&P 500's 8.2% increase. Throughout this period, the sector overall has witnessed a 13.3% increase.